Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry

landmaba
landmaba

Sep 22, 2024, 3:37 AM

Wengler, Kenneth, Trujillo, Paula, Cassidy, Clifford M., & Horga, Guillermo. (2024). Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01934-y

Neuromelanin-sensitive MRI is an advanced imaging technique that can detect neuromelanin, a byproduct of brain chemicals like dopamine and norepinephrine, which are important for regulating mood and emotions. These chemicals are linked to psychiatric disorders such as depression and anxiety. Unlike other methods that require invasive procedures or rely on detecting cell loss, this MRI can provide insights into brain function and chemical activity in a non-invasive way, even before significant damage occurs.

The review paper highlights how this technology is being explored as a tool for studying the underlying mechanisms of psychiatric disorders and for developing new biomarkers—biological indicators that can help diagnose or monitor these conditions. The authors also discuss ongoing research to improve the accuracy of this technique using standardized methods and advanced tools like machine learning and artificial intelligence. These advancements could make neuromelanin-sensitive MRI a key tool in both psychiatric research and clinical practice in the future, offering new ways to assess and personalize treatments for mental health conditions.

Anatomy of catecholaminergic nuclei, neuromelanin synthesis, and neuromelanin-sensitive MRI. Whole brain view (top) indicates
the levels of two brainstem slices (solid black lines) corresponding to the midbrain (left) and the pons (right), where the substantia nigra (SN)
and ventral tegmental area (VTA; together, SN-VTA), and locus coeruleus (LC) can be respectively visualized. Below, neuromelanin-sensitive
MRI (NM-MRI) images are shown (axial view; midbrain/SN-VTA on the left and pons/LC on the right) from a non-clinical individual (with no diagnosis of neuropsychiatric disorders), with the bottom row representing simulated increases in NM-MRI contrast under different psychiatric disorders (note that images are enhanced to exaggerate effects for visual clarity). In the center, from top to bottom, a schematic shows different steps of the neuromelanin synthesis pathways for dopamine and norepinephrine (where copper participates and accumulates more prominently than iron).

Explore Story Topics